ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1166

A New Risk Factor for Predicting the Long-term Outcome of Pulmonary Arterial Hypertension Associated with Connective Tissue Disease: Pulmonary Artery Size Measured by Chest Computed Tomography

xiaodi li1, xiaoxuan sun 1, yinsu zhu 1, Qiang wang 1 and miaojia zhang 2, 1A new risk factor for predicting the long-term outcome of pulmonary arterial hypertension associated with connective tissue disease: pulmonary artery size measured by chest computed tomography, Nanjing, China (People's Republic), 2c, Nanjing, China (People's Republic)

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Connective tissue diseases, pulmonary complications and computed tomography (CT)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 11, 2019

Title: Imaging Of Rheumatic Diseases Poster II

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Most of the prognostic indicators are derived from right cardiac catheterization or biomarkers in patients with CTD-PAH. It is not clear whether the non-invasive parameters measured by chest CT are related to the clinical outcome of patients with CTD-PAH. Therefore, we want to explore whether the size of pulmonary artery measured on chest CT is related to the long-term prognosis of patients with CTD-PAH in Chinese population.

Methods: We retrospectively investigated 140 CTD-PAH patients diagnosed by echocardiography during Jan 2009 and May 2018 at the first affiliated hospital of Nanjing Medical University. The size of pulmonary trunk and its branches was maesured. by two professional radiologists. The primary endpoint was all-cause death. The ability of chest multi-slice CT parameters to predict all cause mortality was tested by time-dependent receiver operating characteristic (ROC) curve and the corresponding cut-off value were defined by difference maximization method.

Results: During the observational period of 3.44 ± 0.23 years, 36 patients were died and the longest survival time was 15 years. The time dependent ROC curve suggested that Main pulmonary artery diameter (MPAd), right pulmonary artery diamete (PRAd) and Left pulmonary artery diameter (LPAd) may have the ability to predict mortality in patients with CTD-PAH , the corresponding cut-off values were 37.70 mm for MPAd, 20.46 mm for RPAd and 20.20 mm for LPAd. Patients with MPAd ≥ 37.70 mm (p=0.00012) and LPAd ≥ 20.20 mm (p=0.0091) exhibited poorer long-term outcome. MPAd ≥ 37.70 mm (HR: 2.74; 95% CI: 1.37-5.48 p=0.004) and WHO functional class III-IV (HR: 3.32; 95% CI: 1.42-7.75 p=0.006) was the independent risk factor of poor outcome for patients with CTD-PAH.

Conclusion: Main pulmonary arterial ≥ 37.70 mm measured by chest multi-slice CT was an independent risk factor of the poor long-term prognosis in Chinese CTD-PAH patients.

Time-dependent ROC curve showing the prognostic value of MSCT parameters

Kaplan-Meier analysis showed significant differences in the prognosis between the patients with MPA diameter <37.70 mm and those with MPA diameter ≥37.70mm

Kaplan-Meier analysis showed significant differences in the prognosis between the patients with LPA diameter <20.20mm and those with LPA diameter ≥ 20.20 mm


Disclosure: x. li, None; x. sun, None; y. zhu, None; Q. wang, None; m. zhang, None.

To cite this abstract in AMA style:

li x, sun x, zhu y, wang Q, zhang m. A New Risk Factor for Predicting the Long-term Outcome of Pulmonary Arterial Hypertension Associated with Connective Tissue Disease: Pulmonary Artery Size Measured by Chest Computed Tomography [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/a-new-risk-factor-for-predicting-the-long-term-outcome-of-pulmonary-arterial-hypertension-associated-with-connective-tissue-disease-pulmonary-artery-size-measured-by-chest-computed-tomography/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-new-risk-factor-for-predicting-the-long-term-outcome-of-pulmonary-arterial-hypertension-associated-with-connective-tissue-disease-pulmonary-artery-size-measured-by-chest-computed-tomography/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology